CA2433962A1 - Compositions antibacteriennes de clarithromycine et processus de preparation connexe - Google Patents
Compositions antibacteriennes de clarithromycine et processus de preparation connexe Download PDFInfo
- Publication number
- CA2433962A1 CA2433962A1 CA002433962A CA2433962A CA2433962A1 CA 2433962 A1 CA2433962 A1 CA 2433962A1 CA 002433962 A CA002433962 A CA 002433962A CA 2433962 A CA2433962 A CA 2433962A CA 2433962 A1 CA2433962 A1 CA 2433962A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- weight
- clarithromycin
- granular
- extra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2433962A CA2433962C (fr) | 2002-07-19 | 2002-07-19 | Compositions antibacteriennes de clarithromycine et processus de preparation connexe |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2433962A CA2433962C (fr) | 2002-07-19 | 2002-07-19 | Compositions antibacteriennes de clarithromycine et processus de preparation connexe |
CA002393614A CA2393614C (fr) | 2002-07-19 | 2002-07-19 | Compositions antibacteriennes de clarithromycine et processus de preparation connexe |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002393614A Division CA2393614C (fr) | 2002-07-19 | 2002-07-19 | Compositions antibacteriennes de clarithromycine et processus de preparation connexe |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2433962A1 true CA2433962A1 (fr) | 2002-10-28 |
CA2433962C CA2433962C (fr) | 2012-10-30 |
Family
ID=4171189
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002393614A Expired - Lifetime CA2393614C (fr) | 2002-07-19 | 2002-07-19 | Compositions antibacteriennes de clarithromycine et processus de preparation connexe |
CA2433962A Expired - Lifetime CA2433962C (fr) | 2002-07-19 | 2002-07-19 | Compositions antibacteriennes de clarithromycine et processus de preparation connexe |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002393614A Expired - Lifetime CA2393614C (fr) | 2002-07-19 | 2002-07-19 | Compositions antibacteriennes de clarithromycine et processus de preparation connexe |
Country Status (1)
Country | Link |
---|---|
CA (2) | CA2393614C (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060110445A1 (en) * | 2002-07-16 | 2006-05-25 | Shashikanth Isloor | Dispersible tablet for oral administration |
TR201010860A2 (tr) * | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Sefdinir formulasyonları için üretim yöntemi. |
TR201009167A2 (tr) * | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Sefalosporin içeren farmasötik granüller. |
-
2002
- 2002-07-19 CA CA002393614A patent/CA2393614C/fr not_active Expired - Lifetime
- 2002-07-19 CA CA2433962A patent/CA2433962C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2393614C (fr) | 2003-09-30 |
CA2433962C (fr) | 2012-10-30 |
CA2393614A1 (fr) | 2002-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3180350B2 (ja) | β―ラクタム系抗生物質含有錠剤およびその製造法 | |
ES2197351T3 (es) | Granulado para la preparacion de composiciones de rapida desintegracion y disolucion que contiene una elevada cantidad de farmaco. | |
US20060034917A1 (en) | Coating of tablet cores | |
KR20010024184A (ko) | 활성 성분으로 클로드로네이트, 부형제로 실리시파이드미세결정성 셀룰로즈를 함유하는 의약 제제 | |
CA2182004C (fr) | Comprimes enrobes de paracetamol et de domperidone | |
KR102684756B1 (ko) | 엔잘루타미드를 함유하는 경구 투여용 의약 조성물 | |
AU759517B2 (en) | Compositions comprising cefuroxime axetil | |
JP5630902B2 (ja) | ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法 | |
KR20040006887A (ko) | 아세트아미노펜을 함유하는 제어방출성의 경구용 제제 | |
CA2435714A1 (fr) | Comprimes de fenofibrate | |
WO2010071320A2 (fr) | Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil | |
US20090155369A1 (en) | Pharmaceutical composition containing levodopa, entacapone and carbidopa | |
CA2433962A1 (fr) | Compositions antibacteriennes de clarithromycine et processus de preparation connexe | |
WO2018029262A1 (fr) | Composition pharmaceutique solide comprenant du sofosbuvir amorphe. | |
JPH04159222A (ja) | 経口投与用固形薬剤の製造方法 | |
WO2020122244A1 (fr) | Comprimé, et procédé de fabrication de celui-ci | |
KR100638315B1 (ko) | 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정 | |
JP2004352633A (ja) | 酸化マグネシウム錠剤 | |
EP2410994A1 (fr) | Composition pharmaceutique contenant de la levodopa, de l'entacapone et de la carbidopa | |
JP2004010575A (ja) | 溶解性を改善した医薬組成物 | |
WO2005021000A1 (fr) | Formes posologiques solides de gatifloxacine a administration par voie orale | |
KR100754239B1 (ko) | 염산세티리진과 염산슈도에페드린을 함유하는 제어방출성의 경구용 제제 및 그의 제조방법 | |
KR20200002486A (ko) | 습식과립 조성물, 이를 함유하는 정제 및 정제의 제조 방법 | |
KR100399524B1 (ko) | 신규경구제약학상제형 | |
RU2023132871A (ru) | Составы в фиксированных дозах |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20220719 |
|
MKEX | Expiry |
Effective date: 20220719 |